We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Century

News List

Century Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares firstwordpharma
June 23, 2021
Century Therapeutics (NASDAQ: IPSC) today announced the closing of its initial public offering of 12,132,500 shares of its common stock at a public offering price of $20.00 per share
Century Therapeutics Significantly Expands Capabilities contractpharma
February 20, 2021
Century Therapeutics, a cell therapy company developing induced pluripotent stem cell (iPSC)-derived cell therapies for cancer, announced a significant expansion of its operational and laboratory space in Philadelphia, as well as progress on its ...